Xie Weiping, Wang Hong, Ding Jianhua, Wang Hai, Hu Gang
Department of Pharmacology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu 210029, China.
Eur J Pharmacol. 2005 Mar 28;511(2-3):81-7. doi: 10.1016/j.ejphar.2005.01.039.
ATP-sensitive potassium (K(ATP)) channels of pulmonary arterial smooth muscle cells (SMCs) have been implicated in pulmonary hypertension. Iptakalim, designed and synthesized by ourselves, is a newly selective K(ATP) channel opener. Here, we explored the effects of iptakalim on the rise of cytoplasmic free Ca(2+) concentration (Ca(2+)) induced by endothelin-1 (ET-1) and on the proliferation of cultured rabbit pulmonary arterial SMCs. The results showed that iptakalim inhibited the Ca(2+) increase. The enhanced [(3)H]thymidine incorporation was inhibited and the transition of cells from static phase (G(0)/G(1)) to DNA synthesis (S) and mitotic phase (G(2)/M) was held back by iptakalim in a concentration-dependent manner. Glyburide abolished the inhibitory effect of iptakalim. In conclusion, we have shown that iptakalim had an inhibitory effect on Ca(2+) increase and the proliferation of pulmonary arterial SMCs induced by endothelin-1 through activation of K(ATP) channels. These findings suggest that iptakalim might be a promising candidate for the treatment of pulmonary arterial remodeling in pulmonary hypertension.
肺动脉平滑肌细胞(SMCs)的ATP敏感性钾通道(K(ATP))与肺动脉高压有关。我们自行设计合成的伊布利特是一种新型的选择性K(ATP)通道开放剂。在此,我们探讨了伊布利特对内皮素-1(ET-1)诱导的细胞质游离钙浓度(Ca(2+))升高以及对培养的兔肺动脉平滑肌细胞增殖的影响。结果表明,伊布利特抑制了Ca(2+)的升高。伊布利特以浓度依赖性方式抑制了增强的[(3)H]胸腺嘧啶核苷掺入,并阻止细胞从静止期(G(0)/G(1))向DNA合成期(S)和有丝分裂期(G(2)/M)的转变。格列本脲消除了伊布利特的抑制作用。总之,我们已表明伊布利特通过激活K(ATP)通道对内皮素-1诱导的Ca(2+)升高和肺动脉平滑肌细胞增殖具有抑制作用。这些发现提示伊布利特可能是治疗肺动脉高压中肺动脉重塑的一个有前景的候选药物。